Skip to Main content Skip to Navigation
Journal articles

[The French mesothelioma network from 1998 to 2013].

Françoise Galateau-Sallé 1, * Anabelle Gilg Soit Ilg 2 Nolwenn Le Stang 1 Patrick Brochard 3 Jean-Claude Pairon 4, 5 Philippe Astoul 6 Catherine Frenay 6 Gaëtane Blaizot 1 Soizick Chamming'S 4, 5 Stéphane Ducamp 2 Thomas Rousvoal 1 Anne de Quillacq 1 Véronique Abonnet 1 Issam Abdalsamad 1 Hugues Begueret 1 Elisabeth Brambilla 1 Frédérique Capron 1 Marie-Christine Copin 1 C. Danel 1 Anne-yvonne de Lajartre 1 Armelle Foulet-Rogé 1 Louise Garbe 1 Odile Groussard 1 S. Giusiano 1 Véronique Hofman 1 Sylvie Lantuejoul 1 Jean-Michel Piquenot 1 Isabelle Rouquette 1 Christine Sagan 1 Françoise Thivolet-Bejui 1 Jean-Michel Vignaud 1 A. Scherpereel 7, 8 Marie-Claude Jaurand 9 D. Jean 9 Pierre Hainaut 10 Laurence Chérié-Challine 2 Marcel Goldberg 2 Danièle Luce 2 Ellen Imbernon 2 
Abstract : Mesothelioma is a rare disease less than 0.3% of cancers in France, very aggressive and resistant to the majority of conventional therapies. Asbestos exposure is nearly the only recognized cause of mesothelioma in men observed in 80% of case. In 1990, the projections based on mortality predicted a raise of incidence in mesothelioma for the next three decades. Nowadays, the diagnosis of this cancer is based on pathology, but the histological presentation frequently heterogeneous, is responsible for numerous pitfalls and major problems of early detection toward effective therapy. Facing such a diagnostic, epidemiological and medico-legal context, a national and international multidisciplinary network has been progressively set up in order to answer to epidemiological survey, translational or academic research questions. Moreover, in response to the action of the French Cancer Program (action 23.1) a network of pathologists was organized for expert pathological second opinion using a standardized procedure of certification for mesothelioma diagnosis. We describe the network organization and show the results during this last 15years period of time from 1998-2013. These results show the major impact on patient's management, and confirm the interest of this second opinion to provide accuracy of epidemiological data, quality of medico-legal acknowledgement and accuracy of clinical diagnostic for the benefit of patients. We also show the impact of these collaborative efforts for creating a high quality clinicobiological, epidemiological and therapeutic data collection for improvement of the knowledge of this dramatic disease.
Document type :
Journal articles
Complete list of metadata

Cited literature [24 references]  Display  Hide  Download
Contributor : Georges Guellaen Connect in order to contact the contributor
Submitted on : Monday, May 26, 2014 - 8:52:00 AM
Last modification on : Monday, January 31, 2022 - 2:52:01 PM
Long-term archiving on: : Tuesday, August 26, 2014 - 10:41:22 AM


Files produced by the author(s)



Françoise Galateau-Sallé, Anabelle Gilg Soit Ilg, Nolwenn Le Stang, Patrick Brochard, Jean-Claude Pairon, et al.. [The French mesothelioma network from 1998 to 2013].. Annales de Pathologie, Elsevier Masson, 2014, 34 (1), pp.51-63. ⟨10.1016/j.annpat.2014.01.009⟩. ⟨inserm-00995995⟩



Record views


Files downloads